Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP22K08567)
Japan Society for the Promotion of Science (JP25K11691)
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 19 August 2025
First Online: 15 September 2025
Declarations
:
: Ryusuke Yoshimi has received speaker fees from GlaxoSmithKline PLC, AstraZeneca PLC, and Sanofi S.A. Natsuki Sakurai and Hideaki Nakajima have no conflict to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: N.S.: conceptualization, validation, and writing—original draft preparation. R.Y.: conceptualization, validation, and writing—review and editing. H.N.: writing—review and editing. All authors read and approved the final version of this manuscript.
